Literature DB >> 10415723

Tissue inhibitors of matrix metalloproteinases in cancer.

L Blavier1, P Henriet, S Imren, Y A Declerck.   

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) play a key regulatory role in the homeostasis of the extracellular matrix (ECM) by controlling the activity of matrix metalloproteinases (MMPs). Some TIMPs have a second function as well, unrelated to their antiMMP activity, which affects cell proliferation and survival. The role of these inhibitors in cancer has been the subject of extensive investigations that have examined their biological activity in tumor growth, invasion, metastasis and angiogenesis, as well as their potential use in the diagnosis and treatment of human cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415723     DOI: 10.1111/j.1749-6632.1999.tb07677.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Serum and biliary MMP-9 and TIMP-1 concentrations in the diagnosis of cholangiocarcinoma.

Authors:  Ali Tüzün İnce; Kemal Yıldız; Venkatanarayana Gangarapu; Yusuf Kayar; Birol Baysal; Oğuzhan Karatepe; Ahu Sarbay Kemik; Hakan Şentürk
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.

Authors:  Jennifer Dien; Hesham M Amin; Neil Chiu; Winson Wong; Christine Frantz; Brian Chiu; John R Mackey; Raymond Lai
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.

Authors:  Ping Pei; Michael P Horan; Russ Hille; Craig F Hemann; Steven P Schwendeman; Susan R Mallery
Journal:  Free Radic Biol Med       Date:  2006-07-15       Impact factor: 7.376

5.  Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma.

Authors:  S Lhoták; L J Elavathil; S Vukmirović-Popović; W C Duivenvoorden; R G Tozer; G Singh
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

6.  Accelerated apoptosis in the Timp-3-deficient mammary gland.

Authors:  J E Fata; K J Leco; E B Voura; H Y Yu; P Waterhouse; G Murphy; R A Moorehead; R Khokha
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

7.  MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2.

Authors:  Fan Yang; Wei Wang; Chunhui Zhou; Wenjin Xi; Lu Yuan; Xu Chen; Yufang Li; Angang Yang; Jianning Zhang; Tao Wang
Journal:  Tumour Biol       Date:  2015-03-04

8.  Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas.

Authors:  Ping Gu; Xiangbin Xing; Marc Tänzer; Christoph Röcken; Wilko Weichert; Audrius Ivanauskas; Matthias Pross; Ulrich Peitz; Peter Malfertheiner; Roland M Schmid; Matthias P A Ebert
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

9.  Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation.

Authors:  Erin M Conn; Mark A Madsen; Benjamin F Cravatt; Wolfram Ruf; Elena I Deryugina; James P Quigley
Journal:  J Biol Chem       Date:  2008-07-24       Impact factor: 5.157

Review 10.  The role of matrix metalloproteinases in the morphogenesis of the cerebellar cortex.

Authors:  Jia Luo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.